Unexplained Liver Disease
You have liver disease, abnormal liver enzymes, or hepatitis without an identified cause, and no family history of liver problems explains it.
AI Summary The alpha-1 antitrypsin (AAT) blood test measures a liver-made protein that protects the lungs. A low level often points to alpha-1 antitrypsin deficiency (AATD), an inherited SERPINA1 condition that can cause cirrhosis and emphysema. Symptoms include breathlessness and jaundice. Doctors order it for unexplained liver or early lung disease, or a family history. Genotype testing confirms the diagnosis. There is no cure; augmentation therapy protects the lungs, while liver care means monitoring, avoiding alcohol, and transplant for advanced cirrhosis.
Source: www.liverdirectory.com
Alpha-1 Antitrypsin (AAT) Test
Medically Reviewed.
The alpha-1 antitrypsin (AAT) blood test measures how much of this liver-made protein is circulating in your blood. AAT normally protects your lungs from a damaging enzyme called neutrophil elastase; a low level often points to alpha-1 antitrypsin deficiency (AATD), an inherited condition caused by mutations in the SERPINA1 gene.
Doctors order this test when someone has unexplained liver disease, early-onset emphysema, or a family history of AATD, because the misfolded protein behind a low blood level also builds up inside liver cells and can injure the liver over time.
This page explains what the AAT test measures, why your doctor might order it, how genotype results such as Pi*MM, Pi*MZ, and Pi*ZZ affect your risk, how AATD is diagnosed and managed, and how to find a liver specialist if you need one.
On this page
Liver Health AI Assistant
Ask Aimy
Turn confusion into a better next question.
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Alpha-1 Antitrypsin Basics
What Is the AAT Test?
Alpha-1 antitrypsin (AAT) is a protein made mainly in the liver. Once released into the bloodstream, it travels to the lungs, where it acts as a protease inhibitor — blocking an enzyme called neutrophil elastase that would otherwise damage delicate lung tissue during normal inflammation.
The AAT blood test measures how much of this protective protein is circulating. A low result suggests alpha-1 antitrypsin deficiency (AATD), an inherited disorder caused by mutations in the SERPINA1 gene. In AATD, the liver still makes AAT, but the protein folds into the wrong shape. Instead of being secreted into the blood, it gets trapped inside liver cells — so too little reaches the lungs to protect them, while the buildup inside liver cells can injure the liver over time.
Because a single blood level can't fully describe this genetic disorder, doctors often pair it with genetic or protein-typing tests that identify your specific AAT genotype, such as Pi*MM (normal), Pi*MZ (carrier), or Pi*ZZ (the classic, most severe form).
AAT Test at a Glance
- AATD is caused by mutations in the SERPINA1 gene and is inherited — two copies of the mutated 'Z' allele, one from each parent, produce the classic Pi*ZZ form.
- AATD affects an estimated 1 in 1,500 to 3,500 people of European ancestry, and about 100,000 Americans live with the condition.
- About 15% of adults with AAT deficiency develop cirrhosis; liver disease can also appear in infancy or early childhood.
- The Pi*ZZ genotype carries the highest genetic risk for liver and lung disease, though the clinical course varies widely from person to person.
- The blood test itself is a routine draw with no procedure involved — genetic testing or a liver biopsy may follow to confirm a diagnosis.
Reasons for AAT Testing
Why You Might Need an AAT Test
Your doctor may order an alpha-1 antitrypsin blood test in several situations.
Early-Onset or Unexplained Lung Disease
You were diagnosed with emphysema before age 45 and never smoked, or you developed lung disease without the usual risk factors like smoking or toxin exposure.
Family History of AATD
A close relative has been diagnosed with alpha-1 antitrypsin deficiency, which raises the chance that you carry a SERPINA1 mutation too.
Infant or Childhood Liver Disease
Cirrhosis or liver disease appearing in infancy or early childhood can be a sign of AATD, since liver involvement often shows up earliest in children.
AAT Test Results Explained
AAT Blood Level and Genotype Reference
AAT results are usually read together with a genotype (protein-typing) result, since the blood level alone can be affected by inflammation.
AAT Blood Level
Total alpha-1 antitrypsin measured in your blood.
Varies by lab
A low level suggests AATD and usually prompts genotype testing to confirm the specific mutation.
A normal level makes clinically significant AATD unlikely, though rare variants can occur with near-normal levels.
AAT is an acute-phase protein, so levels can rise temporarily during infection or inflammation and mask an underlying deficiency.
Pi*MM Genotype
The normal, non-deficient genotype.
Two normal 'M' alleles
Not applicable — this is the reference genotype.
Normal AAT production and secretion; this genotype does not cause AATD.
Not applicable.
Pi*MZ Genotype
One normal allele, one mutated 'Z' allele (carrier).
One M allele, one Z allele
Mildly reduced AAT production is possible, but most carriers do not develop AATD-related disease on their own.
Usually considered a carrier state with low individual risk, though it may add to risk from other liver conditions.
Not applicable.
Pi*ZZ Genotype
Two copies of the mutated 'Z' allele — the classic, most severe form.
Two Z alleles
This genotype produces large amounts of misfolded protein that accumulates in the liver, carrying the highest genetic risk for both liver and lung disease.
Not applicable — Pi*ZZ itself defines the highest-risk group, though clinical severity still varies between individuals.
Not applicable.
Testing Usually Goes Beyond One Number
Because a normal-looking AAT level can still occur with inflammation, and because clinical outcomes vary even within the same genotype, doctors interpret your blood level, genotype result, liver enzymes, and symptoms together — not any single result alone.
AATD Organ Effects
How AATD Affects the Liver and Lungs
AATD affects the liver and lungs differently, and understanding both helps explain why doctors monitor each separately.
Liver Involvement
The misfolded AAT protein accumulates inside liver cells instead of being secreted. Over time this buildup can injure hepatocytes, and about 15% of adults with AATD develop cirrhosis. Liver disease can also begin in infancy or early childhood in some children with the Pi*ZZ genotype.
Lung Involvement
Because too little AAT reaches the lungs, neutrophil elastase goes unchecked during normal inflammation. This raises the risk of emphysema, which often becomes clinically evident in adulthood — especially in people who smoke or are exposed to dust, smoke, or chemical fumes.
Symptoms to Watch For
Symptoms often reflect whichever organ is more affected: shortness of breath, wheezing, a hacking cough, and a barrel-shaped chest point toward lung disease, while jaundice, fatigue, and signs of liver disease point toward liver involvement. Some people have both.
AATD Treatment Options
From Diagnosis to Management
How AATD Is Diagnosed
A doctor typically starts with a physical exam — checking for a barrel-shaped chest or listening for wheezing — alongside the AAT blood test. If the level is low, genetic testing identifies your specific SERPINA1 mutation and genotype, which clarifies your risk more precisely than the blood level alone. Additional tests, such as a lung function test, chest X-ray, CT scan, or arterial blood gases, evaluate lung involvement, while liver enzyme tests and imaging assess liver involvement.
Treating the Lungs: Augmentation Therapy
There is no cure for AATD, and treatment addresses the liver and lungs separately. For lung-directed care, [alpha1-proteinase inhibitor augmentation therapy](/liver-therapies/genetic-liver-disease-therapies/alpha-1-antitrypsin-deficiency/alpha1-proteinase-inhibitor) replaces the missing protein through a weekly intravenous infusion, protecting lung tissue from ongoing damage. This therapy is reserved for adults with severe AATD and clinically significant emphysema — it does not treat or reverse the liver's buildup of abnormal protein.
Treating the Liver: Monitoring and Transplant
For the liver, there's no medication that removes the misfolded protein from liver cells. Management instead focuses on monitoring liver health over time, treating any other liver conditions that develop, and avoiding additional liver stress from alcohol or other toxins. Anyone with AATD who smokes should quit, since smoking accelerates lung damage. In people who progress to advanced cirrhosis or liver failure, liver transplantation can be curative for the liver disease, since a new liver produces normal AAT.
Find a Liver Specialist Near You
Explore Liver Diet
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietSupport Your Diet Alongside Follow-Up Care
The Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
Answers to Common Alpha-1 Antitrypsin (AAT) Test Questions
What does a low alpha-1 antitrypsin level mean?
A low result suggests you may have alpha-1 antitrypsin deficiency (AATD), an inherited condition. Your doctor will likely order genetic testing next to identify your specific genotype, since that clarifies your risk for liver and lung disease more precisely than the blood level alone.
Can inflammation affect my AAT test result?
Yes. AAT is an acute-phase protein, meaning levels can rise temporarily during infection or inflammation. This can mask an underlying deficiency, which is one reason doctors often confirm results with genotype testing rather than relying on the blood level alone.
What does a Pi*ZZ genotype result mean?
The Pi*ZZ genotype means you inherited two copies of the mutated 'Z' allele, one from each parent. It's the classic and most severe form of AATD, carrying the highest genetic risk for both liver and lung disease, though the actual course still varies from person to person.
Does augmentation therapy treat AATD-related liver disease?
No. Alpha1-proteinase inhibitor augmentation therapy replaces the missing protein in your blood to protect your lungs from ongoing damage, but it does not correct or remove the abnormal protein already built up inside your liver cells.
Will I need a liver biopsy to confirm AATD?
Not routinely. Most children and adults with AATD are monitored with blood tests and imaging. A liver biopsy is sometimes used when the diagnosis is unclear or to assess the extent of liver damage, but it isn't required for everyone.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.